Search

everythinglearnresearchcommunity

for

Search:↓

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Finasteride 1.25 mg showed small improvements in hair density and thickness for female pattern hair loss, but more research is needed.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Nanotechnology shows promise for better hair loss treatments but needs more research for safety and effectiveness.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Oral and topical finasteride are effective and safe for treating female hair loss.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

HAIR may cause fetal loss by triggering different cell death processes in the uterus and placenta.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

Isotretinoin may cause temporary, reversible facial hair growth in some women.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

A 71-year-old woman developed male-like features due to high testosterone levels caused by a benign ovarian tumor, which was successfully removed by surgery.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Vertical sleeve gastrectomy improved metabolism, behavior, and reproduction in obese rats with PCOS.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Skin problems like acne and excess hair in PCOS are common and linked to being overweight.

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.